AOBiome begins phase IIb study with B-244 for pruritus in atopic dermatitis June 30, 2020 No Comments
TOPADUR Pharma presents dual PDE5A inhibitors/soluble guanylate cyclase activators June 17, 2020 No Comments
RSS